Morrisons Announces Plans to Close Approximately 100 Stores Amid Government Cost Pressures
Hengli Group Faces Sanctions Chinas SilktoPetrochemicals Empire Confronts US Pressure
Standard Chartered to Trim Over 15 of Corporate Functions Roles in Push for Higher Returns
Saregama India Draws Market Attention After Media Spotlight on Media and Entertainment Sector
Apples AI Journey From Laggard to Potential Winner in the Generative AI Race
Govt Explores Air Force Transport for NEET Papers Amid Exam Leak Crisis
CZFS Q1 2026 Earnings EPS Beats Estimates by Nearly 7 But Stock Slips
Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Losses but Revenue Remains Absent
374Water Inc SCWO Q1 2026 Earnings Narrowing Losses and Commercial Progress Highlight a Quarter of Transition
OXM Q1 2026 Earnings A Significant Earnings Miss Amid Strategic Adjustments
Ascent Industries Co Q1 2025 Earnings EPS Misses Estimates Significantly Stock Declines
RDI Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges
Allied Gaming Entertainment AGAE Slips 367 as Stock Tests Key Support at 056
Asana Stock Slides Amid Weakening Momentum Key Levels to Watch
ABVC BioPharma Consolidates at 139 as Support and Resistance Levels Narrow
Rectitude Holdings RECT Tests Key Support After 366 Decline
Gladstone Commercial Preferred Stock GOODN Shows Minimal Change Amid Tight Trading Range
The Escalating 8 Billion Long COVID Crisis Rising Costs Amidst Federal Retreat
AEVA Q1 2026 Earnings Narrower Loss Beats Expectations Shares Slide
RTX Dips 13 as Defense Sector Faces Headwinds Key Support Levels in Focus
AM Q1 2026 Earnings EPS Misses Estimates Stock Declines 149
GameStop GME Q1 2026 Earnings EPS Surges Past Estimates on Cost Discipline Revenue Remains Undisclosed
PRH Q1 2026 Earnings Strong EPS Surge of 1539 on Solid Operational Performance
RCUS Q1 2026 Earnings WiderthanExpected Loss Highlights Ongoing Biotech Development Costs
Outset Medical Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
KPRX Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares
PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development